Novel benzothiophene-tethered - tethered 1,3,4-oxadiazoles - oxadiazoles as potent antimicrobial targets: Design, synthesis, biological evaluation, DFT exploration and in silico docking study

被引:1
|
作者
Bohurudeen, S. Z. Bava [1 ,2 ]
Ambala, Anilkumar [3 ,4 ]
Allaka, Tejeswara Rao [5 ]
Ahmed, Mohammad Z. [6 ]
Thirunavukkarasu, Balasankar [1 ]
Tirumalareddy, Ramreddy [2 ]
Venkatesan, Srinivasadesikan [7 ]
机构
[1] Annamalai Univ, Dept Chem, Chidambaram 608002, Tamilnadu, India
[2] Apitoria Pharm Pvt Ltd, Apitoria Res Ctr, Sangareddy 502329, Telangana, India
[3] Osmania Univ, Dept Chem, Hyderabad 500007, Telangana, India
[4] Geethanjali Coll Engn & Technol, Dept Chem, Keesara 501301, Telangana, India
[5] Jawaharlal Nehru Technol Univ Hyderabad, Univ Coll Engn Sci & Technol Hyderabad, Ctr Chem Sci & Technol, Hyderabad 500085, Telangana, India
[6] King Saud Univ, Coll Pharm, Dept Pharmacognosy, Riyadh 11451, Saudi Arabia
[7] Technol & Res Univ, Vignans Fdn Sci, Sch Appl Sci & Humanities, Dept Chem, Guntur 522213, Andhra Pradesh, India
关键词
Benzo[ b ]thiophene; 4-oxadiazole; Antibacterial activity; Anti-TB profile; DFT calculation; In silico docking; MYCOBACTERIUM-TUBERCULOSIS; CHALLENGES;
D O I
10.1016/j.molstruc.2024.140251
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Based on previous developments of oxadiazole research programs in trying to find novel compounds with multiple biological targets, such as antibacterial and antitubercular medications. In the context, a new series of 1,3,4-oxadiazole derivatives based on benzo[b]thiophene b ]thiophene moiety 6a-d, - d, 7a - d , and 8a-d - d was synthesized from 5-(3-methylbenzo[b]thiophen-2-yl)-1,3,4-oxadiazole-2-thiol. b ]thiophen-2-yl)-1,3,4-oxadiazole-2-thiol. The structures of 1,3,4-oxadiazole derivatives were elucidated via NMR (1H 1 H and 13 C), IR, and HRMS spectrum data as well as physical data. Subsequently, the derivatives were evaluated for their inhibitory activity against different bacterial microorganisms, and the MICs were determined in vitro tubercular activity against the sensitive M. tuberculosis H37Rv 37 Rv strain. Remarkably, hybrids 6c and 7a exhibited excellent antibacterial activity against S. aureus with ZI values of 31 +/- 0.99, and 30 +/- 0.32 mm, and it has been noticed that 8b demonstrated the most prominent antibacterial efficiency with MICs = 3.1, 3.6, 5.6, and 5.1 mu g/mL against S. pneumoniae, S. pyrogenes, E. coli, , and K. pneumoniae. . Among them, compound 8b , featuring a benzo[b]thiophene b ]thiophene moiety linked to oxadiazole, exhibited a significant tubercular inhibitory effect with an MIC value of 2.2.5 mu M. Additionally, the docked compound 7a showed the strongest key active key amino acids Arg44(A), 44 (A), Arg45(A), 45 (A), Ala126(A), 126 (A), Gly18(A), 18 (A), Ser49(A), 49 (A), Asp48(A) 48 (A) in the antitubercular active site of 1DG5 protein. The study of computer aided ADMET was also carried out, using SwissADME and ADMETlab2.0 to investigate the pharmacokinetic properties of the tested triazole compounds. To support the experimental data, molecular docking and density functional theory (DFT) studies help in understanding the interactions better.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Synthesis, biological evaluation and docking study of some novel isoxazole clubbed 1,3,4-oxadiazoles derivatives
    Ramesh M. Shingare
    Yogesh S. Patil
    Jaiprakash N. Sangshetti
    Rajesh B. Patil
    Dhanji P. Rajani
    Balaji R. Madje
    Medicinal Chemistry Research, 2018, 27 : 1283 - 1291
  • [2] Synthesis, biological evaluation and docking study of some novel isoxazole clubbed 1,3,4-oxadiazoles derivatives
    Shingare, Ramesh M.
    Patil, Yogesh S.
    Sangshetti, Jaiprakash N.
    Patil, Rajesh B.
    Rajani, Dhanji P.
    Madje, Balaji R.
    MEDICINAL CHEMISTRY RESEARCH, 2018, 27 (04) : 1283 - 1291
  • [3] Biological study on novel coumarinyl 1,3,4-oxadiazoles
    Molnar, Maja
    Amic, Ana
    Pavic, Valentina
    Kovac, Tihomir
    Kovac, Marija
    Has-Schon, Elizabeta
    TURKISH JOURNAL OF CHEMISTRY, 2018, 42 (01) : 146 - +
  • [4] SYNTHESIS AND ANTIMICROBIAL EVALUATION OF SOME NEW 1,3,4-OXADIAZOLES
    Godhani, D. R.
    Dobariya, P. B.
    Sanghani, A. M.
    INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY, 2012, 21 (03) : 259 - 262
  • [5] Novel pyrazole integrated 1,3,4-oxadiazoles: Synthesis, characterization and antimicrobial evaluation
    Ningaiah, Srikantamurthy
    Bhadraiah, Umesha K.
    Doddaramappa, Shridevi D.
    Keshavamurthy, Shubakara
    Javarasetty, Chethan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (01) : 245 - 248
  • [6] Synthesis and biological property of some novel 1,3,4-oxadiazoles
    Ramaprasad, G. C.
    Kalluraya, Balakrishna
    Kumar, B. Sunil
    Hunnur, Ravindra K.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (10) : 4587 - 4593
  • [7] Design, synthesis and biological evaluation of novel substituted indazole-1,2,3-triazolyl-1,3,4-oxadiazoles: Antimicrobial activity evaluation and docking study
    Dunga, Ananda Kumar
    Allaka, Tejeswara Rao
    Kethavarapu, Yugandhar
    Nechipadappu, Sunil Kumar
    Pothana, Pradeep
    Ravada, Kishore
    Kashanna, Jajula
    Kishore, Pilli V. V. N.
    RESULTS IN CHEMISTRY, 2022, 4
  • [8] Design, Synthesis and Biological Screening of Novel 1,3,4-Oxadiazoles as Antitubercular Agents
    Tambe, Macchindra S.
    Choudhari, Amit
    Sarkar, Dhiman
    Sangshetti, Jaiprakash
    Patil, Rajesh
    Gholap, Somnath S.
    CHEMISTRYSELECT, 2018, 3 (47): : 13304 - 13310
  • [9] Design, Synthesis, Anticancer Evaluation, and Molecular Docking Studies of Novel Benzoxazole Linked 1,3,4-Oxadiazoles
    Bujji, Sushmitha
    Kumar, Edigi P.
    Sivan, K.
    Manjunatha, D. H.
    Subhashini, N. J. P.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (05) : 933 - 942
  • [10] Design, synthesis, antimicrobial evaluation, and molecular docking studies of novel symmetrical 2,5-difunctionalized 1,3,4-oxadiazoles
    Hkiri, Shaima
    Hafidh, Afifa
    Cavalier, Jean-Francois
    Touil, Soufiane
    Samarat, Ali
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2020, 57 (03) : 1044 - 1054